McManus Matthew bought TECH
August 15, 2025 · Form 4 insider transaction
McManus Matthew bought 9,622 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,622
Price
$0.00
Total value
N/A
InsiderMcManus Matthew
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateAugust 15, 2025
Filing dateAugust 19, 2025
Shares owned after9,622
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.